187 related articles for article (PubMed ID: 31239285)
1.
Baumstark D; Kremer W; Boettcher A; Schreier C; Sander P; Schmitz G; Kirchhoefer R; Huber F; Kalbitzer HR
J Lipid Res; 2019 Sep; 60(9):1516-1534. PubMed ID: 31239285
[TBL] [Abstract][Full Text] [Related]
2. Quantitative NMR-Based Lipoprotein Analysis Identifies Elevated HDL-4 and Triglycerides in the Serum of Alzheimer's Disease Patients.
Berezhnoy G; Laske C; Trautwein C
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293327
[TBL] [Abstract][Full Text] [Related]
3. Quantification of plasma lipoprotein fractions by wavelet transform time-domain data processing of the proton nuclear magnetic resonance methylene spectral region.
Serrai H; Nadal L; Leray G; Leroy B; Delplanque B; de Certaines JD
NMR Biomed; 1998 Oct; 11(6):273-80. PubMed ID: 9802469
[TBL] [Abstract][Full Text] [Related]
4. FT-IR spectroscopy of lipoproteins--a comparative study.
Krilov D; Balarin M; Kosović M; Gamulin O; Brnjas-Kraljević J
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Aug; 73(4):701-6. PubMed ID: 19414281
[TBL] [Abstract][Full Text] [Related]
5. Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models.
Petersen M; Dyrby M; Toubro S; Engelsen SB; Nørgaard L; Pedersen HT; Dyerberg J
Clin Chem; 2005 Aug; 51(8):1457-61. PubMed ID: 15961551
[TBL] [Abstract][Full Text] [Related]
6. Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate.
Yamashita S; Okazaki M; Okada T; Masuda D; Yokote K; Arai H; Araki E; Ishibashi S
J Atheroscler Thromb; 2021 Sep; 28(9):974-996. PubMed ID: 33536398
[TBL] [Abstract][Full Text] [Related]
7. A homogeneous assay to determine high-density lipoprotein subclass cholesterol in serum.
Matsushima-Nagata K; Sugiuchi H; Anraku K; Takao T; Kondo Y; Ishitsuka Y; Irikura M; Irie T; Matsumura T; Araki E; Sumida M; Katayama Y; Kayahara N
Anal Biochem; 2021 Jan; 613():114019. PubMed ID: 33189705
[TBL] [Abstract][Full Text] [Related]
8. The inherent accuracy of 1H NMR spectroscopy to quantify plasma lipoproteins is subclass dependent.
Ala-Korpela M; Lankinen N; Salminen A; Suna T; Soininen P; Laatikainen R; Ingman P; Jauhiainen M; Taskinen MR; Héberger K; Kaski K
Atherosclerosis; 2007 Feb; 190(2):352-8. PubMed ID: 16730730
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women.
Mora S; Otvos JD; Rosenson RS; Pradhan A; Buring JE; Ridker PM
Diabetes; 2010 May; 59(5):1153-60. PubMed ID: 20185808
[TBL] [Abstract][Full Text] [Related]
10. Quantification of biomedical NMR data using artificial neural network analysis: lipoprotein lipid profiles from 1H NMR data of human plasma.
Ala-Korpela M; Hiltunen Y; Bell JD
NMR Biomed; 1995 Sep; 8(6):235-44. PubMed ID: 8732179
[TBL] [Abstract][Full Text] [Related]
11. Plasma lipoprotein distribution in the turkey (Meleagris gallopavo).
Mossab A; Guillaumin S; Lessire M; Milliat F; Hermier D
Comp Biochem Physiol B Biochem Mol Biol; 2001 Sep; 130(2):227-35. PubMed ID: 11544093
[TBL] [Abstract][Full Text] [Related]
12. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
[TBL] [Abstract][Full Text] [Related]
13. Ascites fluid lipoproteins in experimental nephrotic syndrome.
Garber DW; Marsh JB
Biochim Biophys Acta; 1988 Apr; 959(3):253-61. PubMed ID: 3355849
[TBL] [Abstract][Full Text] [Related]
14. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.
Freedman DS; Otvos JD; Jeyarajah EJ; Barboriak JJ; Anderson AJ; Walker JA
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1046-53. PubMed ID: 9672064
[TBL] [Abstract][Full Text] [Related]
15. Nuclear Magnetic Resonance-Based Metabolomics and Risk of CKD.
Geng TT; Chen JX; Lu Q; Wang PL; Xia PF; Zhu K; Li Y; Guo KQ; Yang K; Liao YF; Zhou YF; Liu G; Pan A
Am J Kidney Dis; 2024 Jan; 83(1):9-17. PubMed ID: 37678743
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of 1H NMR lineshape fitting analyses and biochemical lipid analyses of the lipoprotein fractions VLDL, LDL and HDL, and total human blood plasma.
Ala-Korpela M; Hiltunen Y; Jokisaari J; Eskelinen S; Kiviniity K; Savolainen MJ; Kesäniemi YA
NMR Biomed; 1993; 6(3):225-33. PubMed ID: 8347457
[TBL] [Abstract][Full Text] [Related]
17. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
Lyons TJ; Jenkins AJ; Zheng D; Klein RL; Otvos JD; Yu Y; Lackland DT; McGee D; McHenry MB; Lopes-Virella M; Garvey WT;
Diabet Med; 2006 Sep; 23(9):955-66. PubMed ID: 16922701
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
[TBL] [Abstract][Full Text] [Related]
20. Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography.
Okazaki M; Usui S; Ishigami M; Sakai N; Nakamura T; Matsuzawa Y; Yamashita S
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):578-84. PubMed ID: 15637308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
